Despite media attention and public awareness, recent advances in pharmaceutical and medical developments, heart disease in women is under-diagnosed, under-treated, and under-managed. Many women fail to present in the clinic when symptomatic, because of responsibilities at home or at work. Often the first presentation follows a cardiac event. Women are excluded from many clinical trials regardless of age or cardiac history, simply because most trials are aimed at male patients. This best-selling, updated title, aimed at changing this treatment of women's cardiac issues, covers all aspects of female cardiovascular disease. It is required reading for all practitioners who assess female patients.
Section A: Introduction - Importance of Gender Differences, IOM Report Section B: Coronary Heart Disease 1. Epidemiology 2. Coronary Risk Factors in Women . Diabetes and Cardiovascular Disease in Women 4. Risk Intervention Section C: Pregnancy/Oral Contraceptives/Hormonal Therapies 22. Cardiac Disease and Cardiac Surgery in Pregnancy 23. Hypertension in Pregnanct 24. Peripartum Cardiomyopathy 25. Sex Hormones/Physiologic Changes/Genetic Polymorphism 26. Oral Contraceptives 27. Menopausal Hormone Therapy 28. PCOS Section D: Heart Failure 29. Diastolic Dysfunction 30. Heart Failure Section E: Other Cardiovascular Diseases 32. Hypertension 33. Congenital Heart Disease 34. Acquired Valvular Disease 35. Pulmonary Hypertension 36. Anorectic Drugs and the Heart 37. Stroke 38. Arrhythmias and Arrhythmia Management 39. Peripheral Arterial Disease 40. Chronic Renal Insufficiency and CV Disease Section F: Related Issues 41. Pharmacology 42. Stress, Strain and Heart Disease 43. Depression and Heart Disease 44. Women in Cardiovascular Clinical Trials 45. Education of Women About Cardiovascular Health.]
ISBN (PDF) 0-203-67664-5
Title Women & Heart Disease, Second Edition
Author Wenger, Nanette Kass (ed.); Collins, Peter (ed.)
Publisher Taylor & Francis Group